drugset / Trial / NCT02445547
Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease
Phase 1/2
Completed
82 enrolled
Fuzhou General Hospital
Shaanxi Provincial People's Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Stem cell transplantation has emerged as a relatively popular treatment that can help to regulate immunity, repair injury, and control inflammation. Several studies have used autologous stem cells or adipose-derived stem cells to treat Crohn's disease and its associated complications, and have achieved good efficacy. Thus far, the use of umbilical cord mesenchymal stem cells (UC-MSCs) to treat Crohn's disease has rarely been reported. In this study, UC-MSCs were used to treat patients with hormone-controlled Crohn's disease. We observed the disease control conditions, corticosteroid dosage changes, and treatment-related adverse reactions.
Timeline
- Start
- 2012-06
- Primary completion
- 2015-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | — | Intravenous |